CRL Net Income Growth
Charles River Laboratories · Net Income Growth
CRL Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-244.47%period ending
CRL TTM Net Income YoY % (415.46% → -244.47%)
Year-over-year change
High-resolution chart · PNG
CRL net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -244.468% | |
| -485.0204% | |
| -1,501.7481% | |
| -120.2096% | |
| -116.0321% | |
| -107.1927% | |
| -97.8305% | |
| -13.0266% | |
| -10.7935% | |
| -11.5875% | |
| -2.3861% | |
| 8.8351% | |
| 9.1772% | |
| 17.483% | |
| 24.3602% | |
| 10.0352% | |
| 11.9343% | |
| 12.6402% | |
| 7.323% | |
| 31.5576% | |
| 45.9593% | |
| 51.4466% | |
| 44.5542% | |
| 30.3131% | |
| 23.9696% | |
| 8.2054% | |
| 11.3291% | |
| 69.0324% | |
| 69.7313% | |
| 77.1369% | |
| 83.5134% | |
| -30.8388% | |
| -29.5831% | |
| -21.4063% | |
| -20.2953% | |
| 39.3854% | |
| 29.3278% | |
| 6.1227% | |
| 3.6514% | |
| -1.8161% | |
| 1.6955% | |
| 22.9416% | |
| 17.8495% | |
| 21.8864% | |
| 18.5507% | |
| 15.0938% | |
| 23.2135% | |
| 16.1398% | |
| 25.9646% | |
| 13.5305% | |
| 5.6868% | |
| -3.6313% | |
| -9.3075% | |
| -7.8685% | |
| -11.1996% | |
| 140.5932% | |
| 133.7278% | |
| 132.4341% | |
| 132.5441% | |
| -1,167.3357% | |
| -451.5441% | |
| -403.2532% | |
| -394.1857% | |
| 104.3298% | |
| 115.5733% | |
| 119.637% | |
| 121.8737% | |
| -421.7553% | |
| -422.0722% | |
| -434.9724% | |
| -438.8411% | |
| 15.01% | |
| 85.3036% | |
| 99.4969% | |
| 376.7976% | |
| 476.498% | |
| 1,048.3323% | |
| 469.6474% | |
| -139.2841% | |
| -136.3198% | |
| -92.2917% | |
| -85.742% | |
| 58.1422% | |
| 23.5702% | |
| 25.2894% | |
| 27.3692% | |
| 12.0285% | |
| 17.3339% | |
| 10.7688% | |
| 9.3045% | |
| 59.8799% | |
| 85.3721% | |
| 126.4895% | |
| 173.4823% | |
| 41.5878% | |
| 34.3683% | |
| 967.6326% | |
| 634.2025% | |
| 415.4579% |